Precise alteration of promoter, terminator, and operator sequences to fine-tune gene expression in microbial hosts.
Our service targets non-coding regulatory regions to modulate gene output without altering coding sequences, enabling predictable expression control for optimized metabolite or protein production.
We combine computational design and genome editing to precisely modify native regulatory regions, enabling tunable expression of endogenous or heterologous genes in microbial strains.
Bioinformatics analysis identifies candidate regulatory elements (promoters, terminators, operators). Synthetic cassettes with desired strength and inducibility are designed and verified in silico.
Using CRISPR-Cas9 or homologous recombination, the designed cassettes are integrated at the target locus. Edited clones are isolated via selective markers or screening and confirmed by Sanger sequencing.
MRNA (qRT-PCR) and/or protein (reporter assay, Western blot) levels are measured to confirm the intended expression change.
Engineered strains are passaged without selection to evaluate the stability of the regulatory element modification over generations.
Final strains are provided with a validated protocol and analytical data package suitable for scale-up evaluation.
Each project includes a defined set of materials and data to support downstream application.
Every project is defined in a case-by-case scope of work. Typical parameters are listed below.
| Parameter | Typical project scope |
|---|---|
| Host Strain | E. coli, Saccharomyces cerevisiae, Pichia pastoris, Bacillus subtilis, or other bacteria/yeast/fungi upon request |
| Target Regulatory element Type | Promoter (constitutive/inducible), terminator, 5' UTR, ribosome binding site, operator region |
| Editing Method | CRISPR-Cas9 (single guide or multiplex) or homologous recombination with selectable marker |
| Number of Targets | Single locus or up to three loci per project (expanded scope by agreement) |
| Expression Validation | QRT-PCR and/or reporter assay (GFP, luciferase); additional proteomics as scoped |
| Clone Screening Depth | Scoped per project after consultation |
| Stability Study | Scoped per project after consultation |
| Off-target Analysis | In silico prediction for all designed gRNAs; targeted amplicon sequencing of top candidate off-target sites (when scoped) |
A five-step process from target design to delivery of validated engineered strains.
Bioinformatics analysis of the host genome to identify regulatory elements controlling the gene(s) of interest. Design of modified cassettes with defined strength, induction characteristics, and homology arms for integration.
Synthesis and cloning of the designed regulatory cassettes into donor vectors. For CRISPR approaches, gRNAs are designed, cloned, and validated for target specificity.
Delivery of editing components (Cas9/gRNA, donor template) into the host strain via electroporation, chemical transformation, or conjugation. Selection of transformants using antibiotic resistance or auxotrophic markers.
Colony PCR and Sanger sequencing to identify clones with correct integration of the modified regulatory element. Confirmation of homozygosity or heterozygosity as appropriate for the ploidy of the host.
Quantification of target gene expression by qRT-PCR and/or reporter assay. Assessment of phenotypic changes and stability. Delivery of final engineered strain(s) with comprehensive data report.
Fine-tuned expression through regulatory element modification supports diverse industrial and research goals.
Upregulate rate-limiting enzymes or downregulate competing pathways by modulating promoter strength, increasing yield of target metabolites.
Design inducible or constitutive promoters to achieve desired expression levels for therapeutic proteins, enzymes, or industrial biocatalysts.
Precise adjustment of multiple gene expression levels in a heterologous pathway to avoid bottlenecks and evaluate flux.
Answers to typical project-related inquiries.
Modifying a regulatory element (promoter, terminator, etc.) adjusts the expression level of a target gene without removing its coding sequence. A knockout substantially reduce as scoped per project gene function. Our service focuses on expression tuning, not gene deletion.
We routinely work with E. coli, Saccharomyces cerevisiae, Pichia pastoris, and Bacillus subtilis. Other bacteria, yeast, or filamentous fungi can be accommodated through a preliminary feasibility assessment.
Expression is measured by qRT-PCR and/or a reporter assay (e.g., GFP, luciferase) integrated into the locus. Fold-change relative to the parent strain is reported with standard deviation from biological replicates.
Yes, up to three loci can be edited in a single project using multiplexed CRISPR-Cas9 or sequential rounds of modification. Parallel editing efficiency is evaluated during the design phase.
The timeline depends on the number of targets, host strain complexity, and required validations. A detailed project schedule with milestones is provided at project kickoff; typical single-target projects range from 8 to 12 weeks from design to final report.
Get a customized quote for your Strain Gene Regulatory element Modification project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.